These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37504249)

  • 21. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
    Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CD44v3-containing isoforms in head and neck cancer.
    Reategui EP; de Mayolo AA; Das PM; Astor FC; Singal R; Hamilton KL; Goodwin WJ; Carraway KL; Franzmann EJ
    Cancer Biol Ther; 2006 Sep; 5(9):1163-8. PubMed ID: 16855392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of CD44 variant expression in head and neck squamous cell carcinomas.
    Spiegelberg D; Kuku G; Selvaraju R; Nestor M
    Tumour Biol; 2014 Mar; 35(3):2053-62. PubMed ID: 24122205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
    Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
    J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.
    Itai S; Yamada S; Kaneko MK; Chang YW; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):272-281. PubMed ID: 29090976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44s and CD44v6 expression in head and neck epithelia.
    Mack B; Gires O
    PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of metastasis formation by CD44-receptor globulin.
    Zawadzki V; Perschl A; Rösel M; Hekele A; Zöller M
    Int J Cancer; 1998 Mar; 75(6):919-24. PubMed ID: 9506538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct CD44 splice variants differentially affect collateral artery growth.
    Bot PT; Grundmann S; van Royen N; Joosten SP; Schirmer SH; de Kleijn DP; Pals ST; Pasterkamp G; Piek JJ; Hoefer IE
    Curr Vasc Pharmacol; 2013 Jan; 11(1):13-20. PubMed ID: 23391418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer.
    Ishikawa K; Suzuki H; Ohishi T; Nakamura T; Yanaka M; Li G; Tanaka T; Ohkoshi A; Kawada M; Kaneko MK; Katori Y; Kato Y
    Oncol Rep; 2024 Nov; 52(5):. PubMed ID: 39219278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
    Pinner E; Gruper Y; Ben Zimra M; Kristt D; Laudon M; Naor D; Zisapel N
    J Alzheimers Dis; 2017; 58(4):1137-1149. PubMed ID: 28550248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.